Have £5k to invest in UK stocks? Here are my top 3 FTSE 100 shares for May

If you have spare cash available to invest in UK stocks, shares in these top FTSE 100 companies could be a strong buy in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you’re looking to invest £5k in the stock market crash, now could be an ideal opportunity to do so. A fresh sell-off in early May has once again sent the share prices of some top FTSE 100 stocks plunging. 

At the moment, a handful of these look like strong buys to me. Provided investors hold for the long term, I think they offer the prospect of attractive returns and sizeable dividend payouts. So, here’s my selection of top FTSE 100 shares for the month of May.

GlaxoSmithKline

Multinational pharmaceutical company GlaxoSmithKline (LSE: GSK) is on the frontline in the battle against Covid-19. The company recently announced it has joined forces with French healthcare giant Sanofi in the race to create a vaccine.

Whether successful or not, GSK looks well-set to deliver a strong performance this year. First-quarter results were impressive, with group sales rising by 19% to £9.1bn. This was driven by growth across all three of the company’s divisions, with a particularly strong showing from vaccines.

Despite this, GSK’s price-to-earnings ratio sits at a modest 13. For me, this suggests there’s value to be had as I expect high earnings and growth to continue in 2020. For that reason, I think the 4.8% yielding stock is a solid buy this May.

British American Tobacco

Making the jump from medicine to cigarettes, tobacco manufacturing company British American Tobacco (LSE: BATS) is another top FTSE 100 share in my eyes.

The so-called ‘sin stock’ boasts an eye-watering yield of around 7% and has recently pledged to stick to its dividend policy. What’s more, largely thanks to a limited impact on consumer demand, the tobacco company predicts solid earnings growth for 2020.

In line with its target, the FTSE 100 firm forecasts high single figure earnings growth in 2020. This is supplemented by an already strong start to the year, where the company saw its market share rise by 0.2%.

In my view, British American Tobacco’s pledge to stick to its dividend policy is testament to the strength of the company’s financial position. Especially when almost a third of other FTSE 100 companies are cutting or scrapping payments.

A comparatively low price-to-earnings ratio of 9 only sweetens the deal in my eyes. Moreover, steady consumer demand for its products means this company won’t be going anywhere anytime soon.

Reckitt Benckiser

Consumer goods company Reckitt Benckiser (LSE: RB) has seen its share price bounce back from a 20% plunge in the depths of the market crash to now sit 6% up on the start of the year. I think it’s clear to see why.

Last week, the company raised its full-year outlook after it reported a 12.3% rise in first-quarter sales. The impressive results were driven by an increase in demand for the firm’s hygiene products, which include Dettol, Vanish, and Nurofen.

However, with a price-to-earnings ratio of 18, shares don’t come cheap. That said, my expectations of a bumper performance in 2020, driven by unwavering consumer demand, leads me to believe the figure is justified.

All in all, I think these top FTSE 100 stocks are worthy long-term investments. In my view, investors with spare cash to spend could be well-set to profit in the long run from holding shares in each of these companies as they grow their earnings and consolidate their respective market positions.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Matthew Dumigan has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Happy couple showing relief at news
Investing Articles

£5,000 in savings? Here’s how I’d try and turn that into a £308 monthly passive income

It's possible to create a lifelong passive income stream from a well-chosen portfolio of dividend shares. Here's how I'd invest…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Value Shares

This £3 value stock could soar in the AI boom

This under-the-radar value stock could do well on the back of the huge global build-out of data centres in the…

Read more »

Growth Shares

Should I invest in Darktrace shares as they rocket towards £6?

Darktrace shares are up nearly 75% in 2024 as the cybersecurity sector rallied, but is it too late to invest?…

Read more »

Front view photo of a woman using digital tablet in London
Investing Articles

Up 33% in 3 months but Lloyds shares still look undervalued to me

Lloyds shares are finally in demand after a tough few years. While they're more expensive than they were, Harvey Jones…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

The ‘dinosaur’ FTSE 100 index is starting to roar

The FTSE 100 index has often been derided in recent years, but UK large-cap stocks are beginning to show encouraging…

Read more »

Investing Articles

I’d consider buying these FTSE 100 growth stocks for 2024 and beyond

I've been looking for growth stocks with low PEG valuations, and I'm finding plenty. But they're not at all where…

Read more »

Businesswoman calculating finances in an office
Investing Articles

Minimal savings? Here’s how I’d start investing with a Stocks and Shares ISA

A Stocks and Shares ISA is an ideal way for investors to get the most out of their hard-earned money…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

The Rolls-Royce share price frenzy is finally over. Is now the perfect time to buy?

Harvey Jones thinks the Rolls-Royce share price has risen too far, too fast. As investors start to calm down, a…

Read more »